Armata Pharmaceuticals logo

Armata Pharmaceuticals Share Price (NYSE: ARMP)

$2.5

-0.06

(-2.34%)

Last updated on

Check the interactive Armata Pharmaceuticals Stock chart to analyse performance

Armata Pharmaceuticals Inc Key Stats

Check Armata Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.56
Open
$2.59
Market Capitalization
$90.6M
Today's Volume
$5.0K
Revenue TTM
$6.9M
EBITDA
$-33.9M
Earnings Per Share (EPS)
$-1.07
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-3439.35%

Stock Returns calculator for Armata Pharmaceuticals Stock including INR - Dollar returns

The Armata Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Armata Pharmaceuticals investment value today

Current value as on today

₹1,09,451

Returns

₹9,451

(+9.45%)

Returns from Armata Pharmaceuticals Stock

₹4,167 (+4.17%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Armata Pharmaceuticals Stock

35%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Armata Pharmaceuticals Stock from India on INDmoney has increased by 35% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Armata Pharmaceuticals Stock

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Armata Pharmaceuticals(by analysts ranked 0 to 5 stars)

Armata Pharmaceuticals Share Price Target

What analysts predicted

Upside of 260.0%

Target:

$9.00

Current:

$2.50

Armata Pharmaceuticals share price target is $9.00, a slight Upside of 260.0% compared to current price of $2.50 as per analysts' prediction.

Armata Pharmaceuticals Stock Insights

  • Price Movement

    In the last 7 days, ARMP stock has moved down by -4.5%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 491.0K → 2.16M (in $), with an average increase of 77.4% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, 2.6M → -16.29M (in $), with an average decrease of 250.4% per quarter
  • ARMP vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 65.4%
  • ARMP vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 152.5%
  • Price to Sales

    ForARMP every $1 of sales, investors are willing to pay $13.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Armata Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Armata Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Armata Pharmaceuticals Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Armata Pharmaceuticals Inc logo
0.79%
28.64%
6.67%
-34.53%
-15.21%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Armata Pharmaceuticals Inc

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.
Organization
Armata Pharmaceuticals
Employees
60
CEO
Dr. Deborah L. Birx M.D.
Industry
Biotechnology

Key Management of Armata Pharmaceuticals Inc

NameTitle
Dr. Deborah L. Birx M.D.
CEO & Director
Mr. David D. House
Senior VP of Finance & Principal Financial Officer
Dr. Pierre Kyme Ph.D.
Chief Business Officer
Mr. Peter Hubbard
Vice President of Operations
Ms. Bani Tchekanova Ph.D.
Head of Regulatory Strategy & Operations

Important FAQs about investing in ARMP Stock from India :

What is Armata Pharmaceuticals share price today?

Armata Pharmaceuticals share price today is $2.50 as on at the close of the market. Armata Pharmaceuticals share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Armata Pharmaceuticals share?

Armata Pharmaceuticals share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Armata Pharmaceuticals stock price today i.e. is closed at $2.50, lower by 15.54% versus the 52 week high.

How to invest in Armata Pharmaceuticals Stock (ARMP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Armata Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Armata Pharmaceuticals Shares that will get you 0.6000 shares as per Armata Pharmaceuticals share price of $2.50 per share as on August 30, 2025 at 1:28 am IST.

What is the minimum amount required to buy Armata Pharmaceuticals Stock (ARMP) from India?

Indian investors can start investing in Armata Pharmaceuticals (ARMP) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Armata Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Armata Pharmaceuticals share’s latest price of $2.50 as on August 30, 2025 at 1:28 am IST, you will get 4.0000 shares of Armata Pharmaceuticals. Learn more about fractional shares .

What are the returns that Armata Pharmaceuticals has given to Indian investors in the last 5 years?

Armata Pharmaceuticals stock has given -15.21% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?